Trial Outcomes & Findings for Surgical Trial Comparing LIGASURE Assisted Recto-Sigmoid Resection and Omentectomy Compared to Stand (NCT NCT01549925)
NCT ID: NCT01549925
Last Updated: 2016-01-28
Results Overview
To evaluate whether the use of the LIGASURE surgical device during omentectomy and/or recto-sigmoid resection for women with ovarian cancer will reduce the surgical time compared to standard surgical resection using clamps and surgical ligatures
COMPLETED
NA
50 participants
at time of surgery, up to 10 minutes
2016-01-28
Participant Flow
Participant milestones
| Measure |
Standard Surgical Resection
standard surgical resection using clamps and surgical ligatures
Standard Surgical resection: standard surgical resection using clamps and surgical ligatures
|
LIGASURE
Resection using the FDA-approved LIGASURE device during omentectomy and resection of the recto-sigmoid portion of the colon
LIGASURE: resection using the FDA-approved LIGASURE device during omentectomy and resection of the recto-sigmoid portion of the colon
|
|---|---|---|
|
Overall Study
STARTED
|
25
|
25
|
|
Overall Study
COMPLETED
|
25
|
25
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Surgical Trial Comparing LIGASURE Assisted Recto-Sigmoid Resection and Omentectomy Compared to Stand
Baseline characteristics by cohort
| Measure |
Standard Surgical Resection
n=25 Participants
standard surgical resection using clamps and surgical ligatures
Standard Surgical resection: standard surgical resection using clamps and surgical ligatures
|
LIGASURE
n=25 Participants
Resection using the FDA-approved LIGASURE device during omentectomy and resection of the recto-sigmoid portion of the colon
LIGASURE: resection using the FDA-approved LIGASURE device during omentectomy and resection of the recto-sigmoid portion of the colon
|
Total
n=50 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Customized
< 50 years
|
1 Participants
n=5 Participants
|
7 Participants
n=7 Participants
|
8 Participants
n=5 Participants
|
|
Age, Customized
50-70 years
|
16 Participants
n=5 Participants
|
13 Participants
n=7 Participants
|
29 Participants
n=5 Participants
|
|
Age, Customized
>70 years
|
8 Participants
n=5 Participants
|
5 Participants
n=7 Participants
|
13 Participants
n=5 Participants
|
|
Sex: Female, Male
Female
|
25 Participants
n=5 Participants
|
25 Participants
n=7 Participants
|
50 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: at time of surgery, up to 10 minutesTo evaluate whether the use of the LIGASURE surgical device during omentectomy and/or recto-sigmoid resection for women with ovarian cancer will reduce the surgical time compared to standard surgical resection using clamps and surgical ligatures
Outcome measures
| Measure |
Standard Surgical Resection
n=25 Participants
standard surgical resection using clamps and surgical ligatures
Standard Surgical resection: standard surgical resection using clamps and surgical ligatures
|
LIGASURE
n=25 Participants
Resection using the FDA-approved LIGASURE device during omentectomy and resection of the recto-sigmoid portion of the colon
LIGASURE: resection using the FDA-approved LIGASURE device during omentectomy and resection of the recto-sigmoid portion of the colon
|
|---|---|---|
|
Surgical Time
|
417 SECONDS
Interval 378.0 to 455.0
|
338 SECONDS
Interval 296.0 to 379.0
|
Adverse Events
Standard Surgical Resection
LIGASURE
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place